Microbix Biosystems Inc. (MBX.TO)
- Previous Close
0.3400 - Open
0.3500 - Bid 0.3450 x --
- Ask 0.3500 x --
- Day's Range
0.3450 - 0.3500 - 52 Week Range
0.2900 - 0.5500 - Volume
15,418 - Avg. Volume
113,364 - Market Cap (intraday)
49.573M - Beta (5Y Monthly) --
- PE Ratio (TTM)
35.00 - EPS (TTM)
0.0100 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 2, 1999
- 1y Target Est
0.80
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
www.microbix.comRecent News: MBX.TO
View MorePerformance Overview: MBX.TO
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MBX.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MBX.TO
View MoreValuation Measures
Market Cap
49.57M
Enterprise Value
42.97M
Trailing P/E
25.00
Forward P/E
34.97
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.09
Price/Book (mrq)
1.72
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
9.22
Financial Highlights
Profitability and Income Statement
Profit Margin
6.89%
Return on Assets (ttm)
3.27%
Return on Equity (ttm)
5.32%
Revenue (ttm)
22.72M
Net Income Avi to Common (ttm)
1.56M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
14.54M
Total Debt/Equity (mrq)
17.22%
Levered Free Cash Flow (ttm)
991.76k